Hellman & Friedman has selected Goldman Sachs and Morgan Stanley to lead the IPO of security firm Verisure, potentially ...
--Stada's listing plans are still being discussed and subject to change, according to Bloomberg. JPMorgan Chase, Morgan Stanley, Deutsche Bank, and Goldman Sachs are leading the Stada IPO as global ...
A return to the stock exchange however remains the preference, one of the people said. Stada could be valued at around 10 to ...
German pharmaceutical firm Stada said on Tuesday it was generally evaluating all options for its further ownership, including a possible initial public offering. The announcement comes after Bloomberg ...
Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker ...
German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the ...
STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty pharmaceuticals, continued its profitable growth journey in 2024. STADA again outperformed market ...
German generics and consumer healthcare major STADA Arzneimittel (SAZ: Xetra) today released financial results, which the firm said continued its profitable growth journey in 2024 – supported by its ...
Stada Pharmaceuticals, renowned for its over-the-counter medications, is preparing for a significant initial public offering (IPO) in Frankfurt, anticipated for April. The company aims to raise ...
The boss of German healthcare company Stada says his business is a better bet than Big Pharma, as he tries to win over investors ahead of what could be Europe’s biggest IPO this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results